Syndax Pharmaceuticals, Inc. - Common Stock — Cash Flow (NASDAQ:SNDX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -71.26 M29.13 M-133.68 M-160.6 M-274.9 M-322.98 M -278.16 M Cash from investing activities -142.53 M-40.87 M-186.19 M117.61 M-219.78 M290.04 M 234.28 M Cash from financing activities 304.42 M118.46 M172.25 M264.13 M353.37 M13.68 M 20.66 M Free cash flow -71.26 M29.13 M-133.68 M-160.6 M-274.9 M-323.17 M -278.16 M

News

Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Misses Revenue Estimates

Nuvation Bio Inc. (NUVB) Reports Next Week: Wall Street Expects Earnings Growth

Kura Oncology: Commercialization In AML Presents Asymmetric Upside (NASDAQ:KURA)

Syndax Pharmaceuticals, Inc. (SNDX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Syndax Pharmaceuticals at Barclays Conference: Strategic Growth Focus

Syndax at Leerink Conference: Strategic Growth and Profitability

Syndax Pharmaceuticals stock hits 52-week high at $22.91

Syndax at TD Cowen Conference: Strategic Growth and Financial Strength

Stifel raises Syndax Pharmaceuticals stock price target on drug sales

Syndax Pharmaceuticals, Inc. (SNDX) Q4 2025 Earnings Call Transcript

Syndax Q4 2025 slides: revenue surges 50%, profitability path outlined

Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates